Insiders Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen Other stock markets 08:29:49 08/05/2024 pm IST			5-day change	1st Jan Change
2,003 ^DKK	-0.45%		+1.91%	-7.05%

03/05	GENMAB : A good start to 2024; guidance unchanged
03/05	Genmab Posts Q1 Net Profit Surge; Revenue Jumps	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genmab A/S Announces Executive Changes	14/03	CI
Danish Biotechnology Group Genmab Names New Chief Strategy Officer	28/23/28	MT
Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	28/23/28	CI
Avantor Names Jonathan Peacock Chairman	13/22/13	MT
Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	29/22/29	CI
Genmab Announces the Nomination of a New Member of the Company's Board of Directors	15/22/15	AQ
Genmab A/S : Announces the Nomination of a New Member of the Company’s Board of Directors - Form 6-K	14/22/14	PU
Genmab Announces the Nomination of a New Member of the Company’s Board of Directors	14/22/14	GL
Genmab Appoints New Chief Legal Officer, Chief People Officer	01/22/01	MT
Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	01/22/01	CI
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	22/21/22	CI
Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	27/20/27	CI
Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	26/20/26	CI
Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	10/20/10	CI
Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	22/20/22	CI
Genmab A/S Announces Executive Changes	31/19/31	CI
Genmab A/S Announces Management Changes	11/19/11	CI
Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	08/17/08	CI
Genmab A/S Nominates Rolf Hoffmann to its Board of Directors	03/16/03	CI
Genmab A/S Announces Board Appointments	26/15/26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 10:38 pm IST